Human Tissues for Human Therapeutics

Our Mission

Produce novel therapeutics for patients affected by elusive brain diseases

istockphoto1.JPG
 

What We Do

Using our automated microfluidic brain-on-chip technology, we characterize the pharmacological response of candidate therapeutics in human tissues to test the efficacy of candidate drugs

 

Founding Members

The OrganOmics founders met at the University of California - Santa Cruz in 2018. With their diverse technical backgrounds in tissue models, microfabrication, and automation, they were drawn together to generate an advanced research platform to facilitate high velocity drug discovery. OrganOmics was founded in 2021 to carry this revolutionary technology to clinical frontiers.

Gary Mantalas

image0.jpeg

Spencer Seiler

spencer3.jpg

Advisors

 

Dr. David Haussler

david2.jpg

Rob Currie

rcurrie-2021 crop 5.jpg
 
 

Contact Us